Preapproval Formulary Communications: 'What Is Broken?'
Executive Summary
US House bill on preapproval discussions is framed as preventing access delays for future therapies like Gilead’s Sovaldi. But California Democrat Anna Eshoo – whose district abuts Gilead’s headquarters – is skeptical that lack of communication is really the issue.